Trilantic Capital Partners in multiple transactions including its:
- acquisition of WebFX; and
- acquisition of Sofie Biosciences
Greenbriar Equity in its acquisition of Wineshipping
Greenbriar Equity in its acquisition of Applied Aerospace Structures Corporation
Warburg Pincus in connection with BradyIFS’s Merger with Envoy Solutions
Huntsman Corporation in multiple transactions including its:
- $300 million acquisition of CVC Thermoset Specialties;
- $350 million acquisition of Icynene-Lapolla;
- $2.1 billion sale of its chemical intermediates and surfactants businesses to Indorama Ventures; and
- $718 million sale of its textile effects business to Archroma
The Jordan Company in multiple transactions including its:
- acquisition of PQ Corporation’s performance materials business;
- acquisition of AIT Logistics and additional bolt-on acquisitions;
- acquisition of Echo Global Logistics and additional bolt-on acquisitions; and
- partial sale of and reinvestment into iNRCORE
Arya Sciences Acquisition Corp III in its business combination with Nautilus Biotechnology
Arya Sciences Acquisition Corp II in its business combination with Cerevel Therapeutics
Trinseo in the €1.137 billion contemplated acquisition of Arkema’s PMMA business
Arya Sciences Acquisition Corp. in its business combination with Immatics Biotechnologies GmbH
Bristol-Myers Squibb in its $13.4 billion divesture of Celgene’s OTEZLA® program to Amgen in connection with Bristol-Myers Squibb’s $90 billion acquisition of Celgene
Fortive Corporation in Industrial Scientific’s $570 million acquisition of Intelex Technologies
